Project humAn dieTary daTa rEtuRN
Launched by DUKE UNIVERSITY · Feb 12, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called Project humAn dieTary daTa rEtuRN, is studying how sharing information about diet can change eating habits for the better. The researchers believe that when participants receive feedback about their dietary choices—based on stool (poop) samples and special DNA testing—they may be encouraged to eat healthier. This change in diet might also positively affect their gut health and overall well-being.
The study is looking for participants of all ages, including infants, children, and adults, especially those who are already part of another study called Project HOPE 1000. To join, a parent or guardian must be over 18, understand English, and plan to stay in the area for the next two years. Participants will collect stool samples before and after receiving their diet data, helping researchers understand if this feedback really makes a difference. It's important to note that while there are some criteria for joining, there are no specific exclusions for health conditions unless they could affect the study's results. Overall, participating in this study is considered to have minimal risk, mainly relating to privacy concerns.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participant's parent/legal guardian is over age 18 and able to understand English
- • Plans to remain in the area for the next two years
- • Primary caregiver for infant less than 12 months old
- • Able to collect and ship the requested infant stool samples
- Exclusion Criteria:
- There will be no specific exclusions for this study. However, the following biospecimens will not be collected for research purposes from individuals who have a condition that, in the opinion of the site investigators and/or providers, would place the subject at unacceptable risk of injury or confound data interpretation; including but not limited to:
- • Health conditions that impact the infant feeding in a way that may confound interpretation of study results.
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Durham, North Carolina, United States
Durham, North Carolina, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported